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Intracellular Mg2+ concentration (½Mg2þi) and NO regulate cell survival and death. To reveal the
involvement of NO in intracellular Mg2+ regulation, we visualized intracellular Mg2+ using the ﬂuo-
rescent Mg2+ indicator KMG-104-AM in rat hippocampal neurons. Pharmacological experiments
using SNAP, 8-Br-cGMP, diazoxide and several inhibitors revealed that the NO/cGMP/Protein kinsase
G (PKG) signaling pathway triggers an increase in ½Mg2þi, and that Mg2+ mobilization is due to Mg2+
release frommitochondria induced by mitoKATP channel opening. In addition, Mg2+ release is poten-
tiated by the positive feedback loop including mitoKATP channel opening, mitochondrial depolariza-
tion and PKC activation.
 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction are more resistant to the toxic effect of MPTP [16]. In contrast,Magnesium ion (Mg2+) is involved in a wide variety of biochem-
ical reactions, and a multitude of physiological functions are
known to require Mg2+ [1,2]. Major intracellular Mg2+ store is mito-
chondria [3], and the basic mitochondrial functions, including ATP
synthesis, electron transport chain complex subunits, and oxygen
detoxiﬁcation are affected by intracellular Mg2+ [4]. In addition,
cytosolic Mg2+ is found to be a potent inhibitor of mitochondrial
Ca2+ uptake, which cause neuronal toxicity, in physiological
½Mg2þi and [Ca2+]i [5–7] via a putative Mg2+ binding site located
on the cytosolic side of the inner mitochondrial membrane [8]. In
the nervous system, many Mg2+ functions has been implicated in
various neuronal diseases, such as migraine, Alzheimer’s disease
and Parkinson’s disease (PD) [9–11]. Especially, many reports sug-
gest the relationship between Mg2+ contents and the pathology of
PD [9,12–14].
In the brain from patients with PD, neuronal nitric oxide syn-
thase (nNOS) over-expresses [15], and nNOS-gene deﬁcient miceNO activates cGMP/PKG signaling cascade, and modulates a num-
ber of targets including mitochondrial ATP sensitive potassium
channel (mitoKATP) channel [17]. Opening of mitoKATP channel pre-
vents neuronal damage in vitro [18] and in vivo [19] model of PD.
Dietary deﬁciency of Mg2+ in rats induces activation of NO syn-
thase [20]. We demonstrated a gradual decrease in the Mg2+ con-
centration in mitochondria in response to MPP+, which is an
active metabolite of chemical PD inducer MPTP, in differentiated
PC12 cells [21]. These previous reports indicate that the compli-
cated regulatory mechanism between NO signal and change in
½Mg2þi are key players in PD pathology.
However, involvement of NO on Mg2+ regulatory mechanism is
poorly understood. To reveal the involvement of NO signaling on
intracellular Mg2+ dynamics, we investigated the change in
½Mg2þi by using highly sensitive Mg2+ ﬂuorescent probe KMG-
104 during several pharmacological stimulation and inhibition of
hippocampal neurons.
2. Materials and methods
2.1. Cell culture
Primary cultures of hippocampus neurons were prepared from
day 18 embryonic Wister rats (Charles River Laboratories Japan,
Fig. 1. Nitric oxide donor SNAP (100 lM) and PKG activator 8-Br-cGMP (100 lM) induced an increase in ½Mg2þi in cultured hippocampal neurons. Changes in ½Mg2þi was
visualized with KMG-104-AM. (A) Pseudo-colored images of hippocampal neurons. Pseudo-colored images are presented for KMG-104 at the times indicated above when
stimulating with SNAP and 8-Br-cGMP. Colored bars indicate F/F0. Scale bars indicate 50 lm. (B) Averaged time courses of changes in ½Mg2þi . Bath application of 100 lM
SNAP (n = 116, N = 7) and 100 lM 8-Br-cGMP (n = 132, N = 8) induced an increase in ½Mg2þi . Error bars indicate S.E.M. (C) Comparison of the maximum amplitudes of the 8-
Br-cGMP-induced change in ½Mg2þi under normal (n = 132, N = 8) and PKG-inhibited conditions (n = 57, N = 3). PKG inhibitor KT5823 (5 lM) inhibited 8-Br-cGMP-induced
increase in ½Mg2þi . Error bars indicates S.E.M. P < 0.01.
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merged in ice-cold PBS. The neurons were dissociated using a dis-
sociation solution (Sumitomo Bakelite Co., Tokyo, Japan), and the
cells were plated on a poly-D-lysine-coated (Sigma–Aldrich, St.
Louis, MO, USA) glass-bottomed dishes (Iwaki, Tokyo, Japan). The
neurons were cultured in a neurobasal medium supplemented
with B-27, 2 mM L-glutamine, 50 U/ml penicillin, and 50 lg/ml
streptomycin (Invitrogen, Carsbad, CA). Cultures were maintained
at 37 C in a humidiﬁed atmosphere of 5% CO2. Cells were cultured
for a minimum of 4 days before experimental use.
2.2. Dye loading
For intracellular Mg2+ imaging, hippocampal neurons were
incubated with 5 lM KMG-104-AM for 30 min at 37 C. KMG-
104-AM was designed and synthesized as a highly selective ﬂuo-
rescent Mg2+ indicator by our group [22]. Cells were thenwashed twice with Hanks’ balanced salt solution (HBSS) at pH
7.4 (adjusted with NaOH) containing the following: NaCl
(137 mM); KCl (5.4 mM); CaCl2 (1.3 mM); MgCl2 (0.5 mM);
MgSO4 (0.4 mM); Na2HPO4 (0.3 mM); KH2PO4 (0.4 mM); NaHCO3
(4.2 mM); D-glucose (5.6 mM); HEPES (5 mM). Further incubation
was carried out for 15 min to allow complete hydrolysis of the
acetoxymethyl ester of KMG-104-AM in the cells. In some exper-
iments, the cells were incubated for 15 min in HBSS without
Mg2+ (Mg2+-free) during the hydrolysis of acetoxymethyl ester.
In addition, we used HBSS containing the following inhibitors:
500 lM 5-HD, 50 lM glibenclamide, 5 lM KT5823, and 10 lM
Go6983 respectively. These inhibitors are obtained from Sig-
ma–Aldrich (St. Louis, MO, USA) and Tocris Bioscience (Ellisville,
MO, USA). For imaging of Dwm, 25 nM Dwm indicator TMRE
(Invitrogen) was loaded, and 2.5 nM TMRE was remained in
HBSS even during measurement to compensate the dye leakage
from mitochondria.
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Fluorescent imaging experiments were performed using a
confocal laser scanning microscope system (FluoViewFV1000;
Olympus, Tokyo, Japan) mounted on an inverted microscope
(IX81; Olympus) with 60 oil immersion objectives. KMG-104
and TMRE were simultaneously excited at 488 nm from an argon
(Ar) laser and at 559 nm from an helium–neon (HeNe) laser
respectively, and the signals were separated using a 560 nm di-
chroic mirror. Signals from KMG-104 and TMRE were observed
at 500–540 nm and 600–700 nm, respectively. Fluorescent
images were acquired and analyzed utilizing a FluoView soft-
ware package (Olympus). Differences of ﬂuorescent intensities
were then calculated as the mean intensity over a deﬁned region
of interest (ROI).
2.4. Statistical analysis
Signiﬁcant differences were determined by using Student’s t-
test or Tukey’s test for multiple comparisons. P < 0.01 or P < 0.05
was considered signiﬁcantly different, indicated by an asterisk.
2.5. Ethics statement
All animal procedures were approved by the ethical committee
of Keio University (permit number is 09106-(1)).Fig. 2. The Mg2+ source of NO-induced intracellular Mg2+ mobilization is mitochondria. (
Mg2+-free conditions (n = 103, N = 5). The amplitudes of Mg2+ responses are not signiﬁcan
in ½Mg2þi (n = 78, N = 5). After administration of FCCP, application of 100 lM SNAP d
amplitudes of F/F0 in ½Mg2þi before and after application of SNAP following FCCP (n = 78,
signiﬁcantly higher than that after only FCCP stimuli. Error bars indicate S.E.M. P > 0.053. Results
3.1. Increase in ½Mg2þi through NO/cGMP/PKG signaling pathways
We examined whether the stimulation of hippocampal neurons
with NO donor SNAP was able to induce the change in ½Mg2þi.
Application of SNAP to hippocampal neurons induced the increase
of KMG-104 signal, indicating the elevation of the ½Mg2þi (Fig. 1A
and B). This Mg2+ elevation was sustained for more than 20 min.
The main downstream pathway of NO signal is stimulating the
production of cGMP, which activates PKG. To clarify whether cGMP
involves in NO-induced Mg2+ increase, we measured the change in
½Mg2þi when stimulating neurons with the membrane permeable
cGMP analogue, 8-Br-cGMP. The application of 8-Br-cGMP induced
Mg2+ increase as well as the administration of SNAP did (Fig. 1A
and B). This 8-Br-cGMP-induced Mg2+ increase is suppressed by
PKG inhibitor KT5823 (Fig. 1C). These results indicated that the
activation of NO/cGMP/PKG pathway triggers intracellular Mg2+
mobilization.
3.2. Mg2+ release from mitochondria
To investigate whether the source of NO-induced Mg2+ increase
is intracellular or extracellular, we observed the change in ½Mg2þi
when administrating SNAP to hippocampal neurons in Mg2+-free
medium. Even under the Mg2+-free condition, NO induced Mg2+ in-A) Comparison of SNAP-induced change in ½Mg2þi under normal (n = 116, N = 7) and
tly different. Error bars indicate S.E.M. P > 0.05. (B) Averaged time courses of changes
id not induce further increases in both ½Mg2þi . (C) Comparison of the maximum
N = 5). The maximum amplitude of SNAP-induced Mg2+ responses following FCCP is
.
Fig. 3. SNAP- and 8-Br-cGMP-induced ½Mg2þi increase are together with depolar-
ization of mitochondria. Averaged time courses of changes in Dwm by TMRE.
Stimulating hippocampal neurons with SNAP (n = 13, N = 4) and 8-Br-cGMP (n = 27,
N = 4) triggered the decrease in Dwm indicating depolarization of mitochondrial
inner membrane. Error bars indicate S.E.M.
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from intracellular Mg2+ sources. Previously, we demonstrated that
mitochondria are intracellular magnesium stores by the use of
mitochondrial uncoupler FCCP [3,23] and by the simultaneous
imaging of ½Mg2þi and inner-mitochondria Mg2+ [21]. To examine
intracellular source of SNAP-induced Mg2+ increase is mitochon-
dria or the other one, we administrated SNAP following the treat-
ment with FCCP (5 lM). FCCP induces magnesium release from
mitochondria and depletes Mg2+ in mitochondria [23,24]. The
administration of FCCP induced Mg2+ release from mitochondria
as previously descripted (Fig. 2B), and further application of SNAP
induced no further increase in ½Mg2þi (Fig. 2B and C). In addition,
the administration diazoxide following FCCP stimuli also did not
trigger further ½Mg2þi increase (data not shown). These results
suggest that NO induces Mg2+ release from mitochondria.
3.3. Involvement of mitochondrial inner membrane potential in Mg2+
release
FCCP-induced ½Mg2þi increase is due to the depolarization of
the mitochondrial inner membrane [3,23]. To test whether SNAP-
and 8-Br-cGMP- induced Mg2+ release occurs together with mito-
chondrial depolarizing, we simultaneously monitored ½Mg2þi and
Dwm by using KMG-104-AM and TMRE, respectively. The adminis-
tration of SNAP and 8-Br-cGMP depolarized Dwm, respectively
(Fig. 3). The results indicate NO/cGMP/PKG pathways induced
depolarization of mitochondrial inner membrane together with
the Mg2+ release from mitochondria.
3.4. Involvement of mitoKATP channel in Mg
2+ release
The mitoKATP channel activation is known as both downstream
target of PKG and trigger of mitochondrial depolarization [17]. To
clarify whether the mitoKATP channel opening mediates Mg2+
mobilization via NO/cGMP/PKG signaling pathway, we measured
the changes in [Mg2+] by the administration of mitoKATP channel
opener diazoxide (50 lM). The application of diazoxide triggered
the increase in the ½Mg2þi together with depolarization of mito-
chondrial inner membrane (Fig. 4A and B). This SNAP-, 8-Br-cGMP-
and diazoxide-induced Mg2+ increases were suppressed by pre-
treatment of mitoKATP channel blocker, 500 lM 5-HD (Fig. 4C),
and diazoxide-induced Mg2+ increase was not suppressed by PKG
inhibitor, 5 lMKT5823 (Fig. 4D). The pretreatment with 50 lM gli-
benclamide, mitoKATP channel blocker, abolished SNAP-, 8-Br-
cGMP-, and diazoxide-induced ½Mg2þi increase as well as pre-
exposure with 5-HD (data not shown). These results mean that
Mg2+ mobilization activated via SNAP/cGMP/PKG signaling path-
way is mediated by the opening of the mitoKATP channel.
3.5. Positive feedback loop of Mg2+ release mediated by PKC
The mitoKATP channel opening enhances Reactive oxygen spe-
cies (ROS) generation, and ROS generated following mitoKATP chan-
nel opening activates Protein kinase C (PKC) [25]. PKC activation
causes further opening of mitoKATP channels [26–28]. This signal-
ing pathway could act in a positive feedback manner by further
opening or prolonging mitoKATP channels opening [25,27,29]. To
verify whether this positive feedback loop contributes Mg2+ release
from mitochondria via NO/cGMP/PKG pathways, we compared the
amplitudes of Mg2+ responses under normal and PKC inhibited
conditions (Fig. 5). The ½Mg2þi increases induced by application
of SNAP and diazoxide were suppressed by the pretreatment of
the PKC inhibitor Go6987. These results suggest that the activation
of KATP channel opening, stimulated through positive feedback loop
mediated by ROS generation and PKC activation, causes Mg2+ re-
lease from mitochondria.4. Discussion
We demonstrated here that NO induced the increase in ½Mg2þi
mediated by the activation of mitoKATP channel via NO/cGMP/PKG
pathway (Figs. 1–4), and that the positive feedback loop that in-
cludes mitoKATP channel opening and PKC activation, contributes
on this prolonged ½Mg2þi increase (Fig. 5). A stimulatory role of
cGMP/PKG signaling pathway in regulating the function of
mitoKATP channel is reported in neurons [17] and in isolated mito-
chondria from rat heart, liver and brain [30]. Furthermore, it is
known that mitoKATP channel opening via NO/cGMP/PKG signaling
pathway induces mitochondrial ROS generation [31], and that ROS
induces a rapid depolarization of mitochondrial depolarization
[32]. We showed that SNAP and 8-Br-cGMP induce Mg2+ release
from mitochondria and mitochondrial depolarization. Although
NO is known to inhibit respiratory chain by binding to cytochrome
c oxidase, the absence of SNAP-induced ½Mg2þi increase under
inhibition of mitoKATP channel suggested that direct effects of NO
on respiratory chain do not involve in SNAP-induced ½Mg2þi in-
crease. The Mg2+ depletion caused by FCCP abolished further
Mg2+ release from mitochondria after SNAP application. Although
it is unclear whether mitochondrial depolarization triggers Mg2+
release, these results suggest the association of Dwm with
Mg2+ regulatory system of mitochondria. Similar insensitivity of
Mg2+-depleted mitochondria is observed in glutamate-induced
Mg2+ release from mitochondria [23].
Activation of mitoKATP channel confers protection against cell
death in the several disease models such as PD [33,34], traumatic
brain injury [35] and ischemic damagemodels [36]. Recent and lim-
ited study revealed that activation of mitoKATP channels can protect
neurons against some neuronal stress in several neurons [37–39]
including cultured hippocampal neurons [40]. Although the precise
mechanisms involved in the neuroprotective effects by mitoKATP
channel are not clear, it has been suggested the contribution of
mitoKATP channel opening and following mitochondrial depolariza-
Fig. 4. Activation of mitoKATP channel mediates Mg2+ mobilization via NO/cGMP/PKG signaling pathways in cultured hippocampal neurons. Changes in ½Mg2þi andDwm were
visualized with KMG-104-AM and TMRE, respectively. (A) Pseudo-colored images of hippocampal neurons. Pseudo-colored images are presented for KMG-104 at the times
indicated above when stimulating with diazoxide (50 lM). Colored bars indicate F/F0. Scale bars indicate 50 lm. (B) Averaged time courses of changes in ½Mg2þi and Dwm.
Bath application of 50 lM diazoxide induced an increase in ½Mg2þi (top; n = 125, N = 7) and a decrease in Dwm (bottom; n = 10, N = 3). Error bars indicate S.E.M. (C)
Comparison of the maximum amplitudes of the SNAP-, 8-Br-cGMP-, and diazoxide-induced change in ½Mg2þi under normal (n = 116, N = 7; n = 132, N = 8; n = 125, N = 8) and
mitoKATP channel-inhibited conditions (n = 83, N = 4; n = 72, N = 4; n = 62, N = 4). The pretreatment of mitoKATP channel inhibitor 5-HD (500 lM) inhibited SNAP-, 8-Br-cGMP-
and diazoxide-induced increase in ½Mg2þi , respectively. Error bars indicates S.E.M. P > 0.05. (D) Comparison of the maximum amplitudes of the diazoxide-induced change in
½Mg2þi under normal and PKG-inhibited conditions. PKG inhibitor KT5823 (5 lM) did not inhibit diazoxide-induced increase in ½Mg2þi . Error bars indicates S.E.M. P < 0.01.
Fig. 5. Involvement of positive feedback loop including mitoKATP channel opening,
mitochondrial depolarization, ROS generation and PKC activation on Mg2+ mobi-
lization. Comparison of the maximum amplitudes of the SNAP- and diazoxide-
induced change in ½Mg2þi under normal (n = 116, N = 7; n = 125, N = 8) and PKC-
inhibited conditions (n = 87, N = 6; n = 86, N = 7). PKC inhibitor Go6987 (10 lM)
suppressed SNAP- and diazoxide-induced increase in ½Mg2þi . Error bars indicates
S.E.M. P < 0.01.
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death [36]. Intracellular Mg2+ reduces the level of ROS and lessened
p38mitogen-activated protein kinase (MAPK) and c-Jun N-terminal
kinase (JNK) activation, which cause cell death, and plays key role to
control cell survival [41]. We suggested that the positive feedback
signal transduction, including mitoKATP channel opening, ROS gen-
eration and PKC activation, contribute Mg2+ release. In addition,
mitochondrial matrix Mg2+ inhibits gating and conductance of
mitoKATP channels [42]. The mitochondrial Mg2+ extrusion may be
another positive feedback system of mitoKATP channels activation
by removal of the channel blockage. Namely, this Mg2+ release is
prolonged by the contribution of the two positive feedback mecha-
nisms. This prolonged ½Mg2þi increase reduces the level of ROS, and
results in neuronal protection.When ½Mg2þi reach the level enough
to reduce ROS to some extent, prolonged Mg2+ release from
mitochondria ceases since ROS reduction fail to mitoKATP channel
opening through PKC activation. Indeed, activation of mitoKATP
channel with diazoxide result in suppressive effects on UV-induced
MAPK activation [43] and on p38/JNK activation inmicroglia during
rotenone-induced stress [18]. Therefore, the prolonged Mg2+ mobi-
lization mediated NO/cGMP/PKG/mitoKATP channel opening would
continue regulating neuronal functions and result in affecting
neuronal survival and death.In present study, we demonstrated that mitoKATP channel open-
ing through NO/cGMP/PKG signaling pathway triggers Mg2+
release from mitochondria with concomitant mitochondrial depo-
larization, and that PKC activity modulates this Mg2+ regulatory
2648 R. Yamanaka et al. / FEBS Letters 587 (2013) 2643–2648system. Although intracellular Mg2+ regulatory roles of mitoKATP
channel through NO/cGMP/PKG signaling pathway are elucidated,
the molecular mechanism underlying mitochondrial Mg2+ regula-
tory roles are still not clear. In the future, further studies are
needed to uncover the mitochondrial Mg2+ regulatory mechanism
in molecular level.
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